High throughput testing of the SV40 Large T antigen binding to cellular p53 identifies putative drugs for the treatment of SV40-related cancers

Virology. 2003 Oct 25;315(2):409-14. doi: 10.1016/s0042-6822(03)00547-6.

Abstract

SV40 has been linked to some human malignancies, and the evidence that this virus plays a causative role in mesothelioma and brain tumors is mounting. The major SV40 oncoprotein is the Large tumor antigen (Tag). A key Tag transforming activity is connected to its capability to bind and inactivate cellular p53. In this study we developed an effective, high throughput, ELISA-based method to study Tag-p53 interaction in vitro. This assay allowed us to screen a chemical library and to identify a chemical inhibitor of the Tag binding to p53. We propose that our in vitro assay is a useful method to identify molecules that may be used as therapeutic agents for the treatment of SV40-related human cancers.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigens, Polyomavirus Transforming / metabolism*
  • Antineoplastic Agents / pharmacology*
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Polyomavirus Infections / drug therapy*
  • Simian virus 40 / drug effects*
  • Tumor Suppressor Protein p53 / metabolism*
  • Tumor Virus Infections / drug therapy*

Substances

  • Antigens, Polyomavirus Transforming
  • Antineoplastic Agents
  • Tumor Suppressor Protein p53